Kapak Resmi

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy

Proteolysis-targeting chimeras (PROTACs) are rapidly emerging as a potential therapeutic strategy for cancer therapy by inducing the degradation of tumor-overexpressing oncogenic proteins. They can specifically catalyze the degradation of target oncogenic proteins by recruiting E3 ligases and utiliz...

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Yujeong Moon (Yazar), Seong Ik Jeon (Yazar), Man Kyu Shim (Yazar), Kwangmeyung Kim (Yazar)
Materyal Türü:	Kitap
Baskı/Yayın Bilgisi:	MDPI AG, 2023-01-01T00:00:00Z.
Konular:	article
Online Erişim:	Connect to this object online.
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

A Mechanistic Pharmacodynamic Modeling Framework for the Assessment and Optimization of Proteolysis Targeting Chimeras (PROTACs)
Yazar:: Robin Thomas Ulrich Haid, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Proteolysis-targeting chimeras and their implications in breast cancer
Yazar:: Angeles C. Tecalco-Cruz, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1
Yazar:: Mingxing Hu, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The clinical advances of proteolysis targeting chimeras in oncology
Yazar:: Hao Xie, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

PROteolysis Targeting Chimeras: A new cutting‐edge nanomedicine for colorectal cancer
Yazar:: Swastika Maitra, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Research advances of proteolysis targeting chimeras for acute kidney injury
Yazar:: Jun-dan Jia, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
Yazar:: Yang Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Tear exosome‐based PROteolysis TArgeting Chimeras nanomedicine for human immunodeficiency virus‐mediated cancer treatment
Yazar:: Nobendu Mukerjee
Baskı/Yayın Bilgisi: (2024)

Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs
Yazar:: Rohan Kalyan Rej, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges
Yazar:: Chao Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation
Yazar:: Hanhee Cho, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Use of Poly(vinyl alcohol) in Spray-Dried Dispersions: Enhancing Solubility and Stability of Proteolysis Targeting Chimeras
Yazar:: Lena Mareczek, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer's disease model mice
Yazar:: Dongping Yao, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug
Yazar:: BoRa Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
Yazar:: Yujeong Moon, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

The proteolysis targeting chimera GMB-475 combined with dasatinib for the treatment of chronic myeloid leukemia with BCR::ABL1 mutants
Yazar:: Wu Ye, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
Yazar:: Hanhee Cho, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
Yazar:: Si-Min Qi, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
Yazar:: Arvind Negi, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

PROTACs targeting epigenetic proteins
Yazar:: Chao Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner
Yazar:: Miao Zeng, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Exosome‐based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV‐mediated cervical cancer treatment
Yazar:: Nobendu Mukerjee, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Application of PROTACs in target identification and validation
Yazar:: Yang Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Chimera World
Yazar:: Peacock, Wilbur S., 1911-1979

Proteostasis and Proteolysis
Baskı/Yayın Bilgisi: (2022)

Proteostasis and Proteolysis
Baskı/Yayın Bilgisi: (2022)

PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
Yazar:: Yulu Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

PROTACs for BRDs proteins in cancer therapy: a review
Yazar:: Chao Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids
Yazar:: Yanli Wu, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Neuroplasticity and Extracellular Proteolysis
Yazar:: Leszek Kaczmarek
Baskı/Yayın Bilgisi: (2016)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
Yazar:: Yongwhan Choi, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy
Yazar:: Abu Baker, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Editorial: Targeted Immunotherapy for Cancer
Yazar:: Williams V. Williams
Baskı/Yayın Bilgisi: (2022)

Targeting neoantigens for cancer immunotherapy
Yazar:: Xuan Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Chimera States in Complex Networks
Baskı/Yayın Bilgisi: (2020)

An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment
Yazar:: Yuzhu Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

mRNA delivery in cancer immunotherapy
Yazar:: Yichen Zhong, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Cancer Immunotherapy and Delivery System: An Update
Yazar:: Ming Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy
Yazar:: Youngjoo Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
Yazar:: Sinan Ma, ve diğerleri
Baskı/Yayın Bilgisi: (2022)